STVN Stevanato Group Accounting Capitalization

STVN (stevanatogroup.com) - company brandmark

This chart reflects that the asset value of Stevanato Group S.p.A. (STVN) is subject to the impact of disruptions in global transport routes, which complicates the delivery of glass containers. The current indicator is 0.32. The Italian manufacturer is valued for the impeccable purity of its vials, earning recognition from global biopharma behemoths. Meanwhile, political risks remain minimal, as diversified sales channels in Europe and America guarantee business resilience.

STVN Stevanato Group Book Capitalization (07/04/2022 - 10/28/2026)

Stevanato Group (STVN) - metric breakdowns and financial figures

- price and consensus price forecast:
Price Chart Stevanato Group Corp|STVN - Price Target Chart
- market capitalization data:
Market Capitalization Stevanato Group SpA|STVN - Total Company Value
- book capitalization data:
Accounting Value per Share Stevanato Group|STVN - Book Capitalization|Market-to-Book Ratio stevanatogroup.com|STVN - Company Total Assets
- debt and liquidity data:
Debt to Equity Ratio Stevanato Group S.p.A.|STVN - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Stevanato Group SpA|STVN - Company Aggregate Debts|Debt to Book Value Stevanato Group SpA|STVN - Company Long-Term Debts|Company Short-Term Debts Stevanato Group
Fundamental valuation:STVN - Stevanato Group Corp
Mass-produced product of Stevanato

High regulatory protection and stable demand for Stevanato Group S.p.A. (STVN) glass packaging ensure the predictability of its equity. This chart of the company's accounting capitalization reflects the value of net assets, allowing investors to differentiate fundamental stability from market noise, where excessive values signal inefficient cash utilization and a decline indicates a risk of asset base impairment.

Competitor analysis for Stevanato Group S.p.A.

ISRG: Company Book Value|Company Book Value Danaher Corp.|BDX (bd.com) - Accounting Capitalization|Company Book Value STE|Company Net Assets West Pharma|Baxter Corp - Book Capitalization|Total Stockholders' Equity Masimo Inc. (MASI)|TFX - Book Capitalization|Accounting Capitalization merit.com MMSI|Book Capitalization NVST (Envista)|ICUI - Book Valuation of Business|XRAY (Dentsply) - Book Capitalization|LeMaitre Corp (LMAT) - Company Net Assets|ATRC (AtriCure, Inc.) - Book Capitalization|Book Capitalization STAA|Company Book Value ChromaDex Corporation (NAGE)|Company Book Value ZimVie Inc ZIMV|Company Net Assets AngioDynamics Corp|Accounting Value of Company Cerus Inc CERS|Book Capitalization TKNO (Alpha Teknova, Inc.)|MGRM: Book Valuation of Business|Company Book Value sharpstechnology.com|INFU (InfuSystem Holdings, Inc.) - Accounting Capitalization|UTMD: Company Book Value|Book Valuation of Business KORU Medical Systems Inc. (KRMD)|Company Net Assets Nyxoah S.A.|Total Net Assets MBOT (microbotmedical.com)|Company Book Value Pro-Dex|ZTEK - Accounting Value of Company|Elutia Corp - Company Net Assets|MLSS: Book Capitalization|NXGL (NEXGEL, Inc.) - Company Book Value|Retractable Technologies, Inc. (RVP) - Company Net Assets|Book Capitalization HBIO (Harvard Bioscience, Inc.)|Total Stockholders' Equity FEMY|Company Book Value MeihuaMed MHUA|Accounting Capitalization predictive-oncology.com POAI|Company Net Assets Callan JMB (CJMB)|atrioncorp.com - Total Net Assets|Company Book Value NURO (NeuroMetrix)